INVEGA (Janssen Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the INVEGA drug offered from Janssen Pharmaceuticals, Inc.. This Atypical Antipsychotic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Janssen Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | paliperidone |
SUBSTANCE NAME: | PALIPERIDONE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Atypical Antipsychotic [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2006-12-19 |
END MARKETING DATE: | 0000-00-00 |
INVEGA HUMAN PRESCRIPTION DRUG Details:
Item Description | INVEGA from Janssen Pharmaceuticals, Inc. |
LABELER NAME: | Janssen Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 3(mg/1) |
START MARKETING DATE: | 2006-12-19 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 50458-550_bb9d092b-52c8-467d-bb3c-ea5f60b5da5c |
PRODUCT NDC: | 50458-550 |
APPLICATION NUMBER: | NDA021999 |
Other PALIPERIDONE Pharmaceutical Manufacturers / Labelers: